KRAS Mutation Analysis of Single Circulating Tumor Cells From Patients With Metastatic Colorectal Cancer

BMC Cancer - United Kingdom
doi 10.1186/s12885-017-3305-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Isolation and Genomic Analysis of Circulating Tumor Cells From Castration Resistant Metastatic Prostate Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2012English

Cancer Panel Analysis of Circulating Tumor Cells in Patients With Breast Cancer

Oncology Letters
Cancer ResearchOncology
2018English

P16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients With Metastatic Colorectal Cancer

Cancer Research and Treatment
Cancer ResearchOncology
2016English

Detection of Circulating Tumor Cells in Colorectal Cancer Patients Using the Gilupi CellCollector: Results From a Prospective, Single Center Study

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2019English

Mutation Pattern of KRAS and BRAF Oncogenes in Colorectal Cancer Patients

Neoplasma
Cancer Research
2012English

53BP1 Accumulation in Circulating Tumor Cells Identifies Chemotherapy-Responsive Metastatic Breast Cancer Patients

Cancers
Cancer ResearchOncology
2020English

Clinical-Pathological Correlation of KRAS Mutation Status in Metastatic Colorectal Adenocarcinoma

World Journal of Oncology
Cancer ResearchOncology
2013English

HER2 Genomic Amplification in Circulating Tumor DNA From Patients With Cetuximab-Resistant Colorectal Cancer

Oncotarget
Oncology
2015English

Prevalence of KRAS, BRAF, PI3K and EGFR Mutations Among Asian Patients With Metastatic Colorectal Cancer

Oncology Letters
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy